Evidence for impaired mnemonic strategy use among patients with schizophrenia using the part-list cuing paradigm.

Abstract:

PURPOSE:Strategic and mnemonic abilities of person with schizophrenia (SCZ) were studied using a part-list cuing (PLC) task. In this task, presentation of retrieval cues in the form of a subset of studied words typically impairs recall of the remaining items. This impairment is thought to reflect a disruption of participants' natural retrieval strategies. METHODS:Participants with SCZ and healthy controls (ns = 28) studied word lists with three different levels of semantic organization: (a) unrelated, (b) categorized, but presented in a random order, and (c) presented by category. For each type of list, participants recalled words under both free-recall and PLC conditions. RESULTS:Consistent with SCZ-related impairment of strategic retrieval processes, the SCZ group was less disrupted by PLC interference than controls in the unrelated-list condition. Comparison of free recall across lists also indicated a consistent deficit in SCZ despite varying levels of difficulty and retrieval contexts. Nonetheless, the SCZ group demonstrated parallel improvement to the healthy group with increasing list organization. CONCLUSIONS:These results provide evidence of deficient retrieval processes in SCZ in a context placing maximal requirements for utilization of self-initiated, effortful, mnemonic strategies. Unlike most extant results demonstrating mnemonic impairment in persons with SCZ, the present results cannot be accounted for by task difficulty; SCZ participants' recall was less disrupted by PLC than was that of healthy participants. Results also demonstrated that SCZ participants could benefit, in terms of recall and strategy use, from list organization when this structure was explicitly provided at test.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Christensen BK,Girard TA,Benjamin AS,Vidailhet P

doi

10.1016/j.schres.2006.03.001

subject

Has Abstract

pub_date

2006-07-01 00:00:00

pages

1-11

issue

1-3

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(06)00089-2

journal_volume

85

pub_type

杂志文章
  • Schizotypal dimensions: continuity between schizophrenia and bipolar disorders.

    abstract:BACKGROUND:Family studies have suggested that schizophrenia and bipolar disorders share some susceptibility factors. Schizotypal personality disorder (SPD) may be an intermediate phenotype common both to schizophrenia and bipolar disorders. We explored the familiality of schizotypal dimensions by comparing the magnitud...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.07.009

    authors: Schürhoff F,Laguerre A,Szöke A,Méary A,Leboyer M

    更新日期:2005-12-15 00:00:00

  • Computational approaches to schizophrenia: A perspective on negative symptoms.

    abstract::Schizophrenia is a heterogeneous spectrum disorder often associated with detrimental negative symptoms. In recent years, computational approaches to psychiatry have attracted growing attention. Negative symptoms have shown some overlap with general cognitive impairments and were also linked to impaired motivational pr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2016.10.004

    authors: Deserno L,Heinz A,Schlagenhauf F

    更新日期:2017-08-01 00:00:00

  • Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNO.

    abstract:BACKGROUND:All currently available antipsychotic medications bind to both the dopamine-2 (D2) and dopamine-3 (D3) receptors in vitro. However, there is conflicting evidence from in vivo studies about whether or not antipsychotic medications bind to the D3 receptor (D3R). The purpose of this study was to determine wheth...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.06.027

    authors: Girgis RR,Xu X,Gil RB,Hackett E,Ojeil N,Lieberman JA,Slifstein M,Abi-Dargham A

    更新日期:2015-10-01 00:00:00

  • Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics.

    abstract::The 24-h profiles of plasma melatonin and cortisol were evaluated in 7 drug-free male paranoid schizophrenics and in 7 healthy subjects matched to the patients for age, sex, body weight, height and season of testing. Blood samples were obtained at 20.00, 22.00, 24.00, 01.00, 02.00, 06.00, 08.00 and 12.00 h. Light was ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(92)90077-i

    authors: Monteleone P,Maj M,Fusco M,Kemali D,Reiter RJ

    更新日期:1992-04-01 00:00:00

  • Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia.

    abstract:BACKGROUND:Some patients develop breakthrough psychotic symptoms on antipsychotic maintenance medication (BAMM), despite receiving therapeutic antipsychotic doses to which they previously responded. METHODS:We examined the occurrence of BAMM in previously minimally treated first-episode patients with schizophrenia-spe...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.11.025

    authors: Emsley R,Asmal L,Rubio JM,Correll CU,Kane JM

    更新日期:2020-11-01 00:00:00

  • White matter alterations and the conversion to psychosis: A combined diffusion tensor imaging and glutamate 1H MRS study.

    abstract:INTRODUCTION:Widespread white matter abnormalities and alterations in glutamate levels have been reported in patients with schizophrenia. We hypothesized that alterations in white matter integrity and glutamate levels in individuals at clinical high risk (CHR) for psychosis are associated with the subsequent developmen...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2020.06.006

    authors: León-Ortiz P,Reyes-Madrigal F,Kochunov P,Gómez-Cruz G,Moncada-Habib T,Malacara M,Mora-Durán R,Rowland LM,de la Fuente-Sandoval C

    更新日期:2020-06-25 00:00:00

  • Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis.

    abstract:OBJECTIVE:The use of dopaminergic antagonist antipsychotics is associated with hyperprolactinemia, but some studies have found increased prolactin concentrations in antipsychotic-naive patients with schizophrenia and related disorders. We conducted a systematic review and meta-analysis of studies of prolactin in antips...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.schres.2016.03.018

    authors: González-Blanco L,Greenhalgh AMD,Garcia-Rizo C,Fernandez-Egea E,Miller BJ,Kirkpatrick B

    更新日期:2016-07-01 00:00:00

  • The association between schizophrenia and the immune system: Review of the evidence from unbiased 'omic-studies'.

    abstract::A role for immune processes in the pathogenesis of schizophrenia has been suggested by genetic and epidemiological studies, as well as cross-sectional studies on blood and brain samples. However, results are heterogeneous, which is likely caused by low samples sizes, insufficient control of confounders that influence ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.05.028

    authors: van Mierlo HC,Schot A,Boks MPM,de Witte LD

    更新日期:2020-03-01 00:00:00

  • Corpus callosum development in childhood-onset schizophrenia.

    abstract:OBJECTIVE:Corpus callosum (CC) size and interhemispheric communication differences have been reported between patients with schizophrenia and normal controls. Childhood-onset schizophrenia (COS) is a severe form of the disorder that is continuous with later-onset disorder. Corpus callosal area was examined for COS at i...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(02)00354-7

    authors: Keller A,Jeffries NO,Blumenthal J,Clasen LS,Liu H,Giedd JN,Rapoport JL

    更新日期:2003-07-01 00:00:00

  • Decreased expression of a 40-kDa catecholamine-regulated protein in the ventral striatum of schizophrenic brain specimens from the Stanley Foundation Neuropathology Consortium.

    abstract::The majority of heat shock proteins (HSP) act as molecular chaperones protecting cells from deleterious stress. These proteins are able to inhibit the aggregation of partially denatured proteins and refold them into the correct conformation. They have also been shown to be involved in the pathogenesis of many neurodeg...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2004.03.025

    authors: Gabriele JP,Chong VZ,Pontoriero GF,Mishra RK

    更新日期:2005-04-01 00:00:00

  • Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.

    abstract:BACKGROUND:The 22q11.2 deletion syndrome (22q11DS) is one of the highest known risk factors for schizophrenia and recent findings have highlighted the clinical relevance of ultra-high risk (UHR) criteria in this population. However, studies in other at-risk populations have shown that the presence of negative symptoms ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.10.014

    authors: Schneider M,Armando M,Schultze-Lutter F,Pontillo M,Vicari S,Debbané M,Eliez S

    更新日期:2019-04-01 00:00:00

  • Effect of psychotropic drug treatment on sterol metabolism.

    abstract::Cholesterol metabolism is vital for brain function. Previous work in cultured cells has shown that a number of psychotropic drugs inhibit the activity of 7-dehydrocholesterol reductase (DHCR7), an enzyme that catalyzes the final steps in cholesterol biosynthesis. This leads to the accumulation of 7-dehydrocholesterol ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2017.02.001

    authors: Korade Ž,Liu W,Warren EB,Armstrong K,Porter NA,Konradi C

    更新日期:2017-09-01 00:00:00

  • Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome.

    abstract::Recently, apolipoprotein D (apoD), a protein that is involved in the essential polyunsaturated fatty acid (EPUFA) transport and metabolism, and neuronal growth and regeneration was reported to have increased in the postmortem brain and decreased in the serum of schizophrenia patients. We studied the plasma apoD levels...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(01)00378-4

    authors: Mahadik SP,Khan MM,Evans DR,Parikh VV

    更新日期:2002-11-01 00:00:00

  • Delay discounting and affective priming in individuals with negative schizotypy.

    abstract::Previous studies have demonstrated that patients with schizophrenia and individuals with schizotypy experience decreased anticipatory pleasure. However, it is unclear whether this decrease is contributed by altered reward processing at the proximal or distal future. In order to investigate the preference for receiving...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.12.040

    authors: Cai XL,Weigl M,Liu BH,Cheung EFC,Ding JH,Chan RCK

    更新日期:2019-08-01 00:00:00

  • Emergency department utilization among Medicaid beneficiaries with schizophrenia and diabetes: the consequences of increasing medical complexity.

    abstract:OBJECTIVE:Individuals with both physical and mental health problems may have elevated levels of emergency department (ED) service utilization either for index conditions or for associated comorbidities. This study examines the use of ED services by Medicaid beneficiaries with comorbid diabetes and schizophrenia, a dyad...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.12.002

    authors: Shim RS,Druss BG,Zhang S,Kim G,Oderinde A,Shoyinka S,Rust G

    更新日期:2014-02-01 00:00:00

  • BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis.

    abstract:BACKGROUND:Evidence indicating that symptoms of non-clinical psychosis (NCP) occur in 6-8% of the general population suggests that psychosis may occur across a continuum. Although a number of studies have examined environmental contributors, to date there have been few investigations of biological/genetic factors in th...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.06.018

    authors: Mittal VA,Smolen A,Dean DJ,Pelletier AL,Lunsford-Avery J,Smith A

    更新日期:2012-09-01 00:00:00

  • Analysis of differential gene expression mediated by clozapine in human postmortem brains.

    abstract::Clozapine is the only medication indicated for treating refractory schizophrenia, due to its superior efficacy among all antipsychotic agents, but its mechanism of action is poorly understood. To date, no studies of human postmortem brain have characterized the gene expression response to clozapine. Therefore, we addr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.schres.2016.12.017

    authors: Lee BJ,Marchionni L,Andrews CE,Norris AL,Nucifora LG,Wu YC,Wright RA,Pevsner J,Ross CA,Margolis RL,Sawa A,Nucifora FC Jr

    更新日期:2017-07-01 00:00:00

  • The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.

    abstract:BACKGROUND:Many patients with schizophrenia suffer from metabolic symptoms and weight gain in which predispose them to obesity, diabetes, and cardiovascular problems. This trial examines the efficacy and safety of zonisamide on weight and body mass index in patients with schizophrenia being administered with atypical a...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2013.03.021

    authors: Ghanizadeh A,Nikseresht MS,Sahraian A

    更新日期:2013-06-01 00:00:00

  • Deficits in sustained attention in schizophrenia but not in bipolar disorder.

    abstract::The aim of the present study was to investigate sustained attention in remitted patients with bipolar disorder and in patients with schizophrenia, as compared to each other and to healthy controls; a secondary aim was to investigate the correlations of different symptom dimensions with performance on sustained attenti...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.05.014

    authors: Bozikas VP,Andreou C,Giannakou M,Tonia T,Anezoulaki D,Karavatos A,Fokas K,Kosmidis MH

    更新日期:2005-10-15 00:00:00

  • Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia.

    abstract:BACKGROUND:Cognitive impairment is a core feature of schizophrenia. Some evidence suggests an association between cognition deficits and gray matter reductions. In this study, we investigated the relationship between cognitive performance and gray matter volumes in patients with treatment-naïve, first-episode schizophr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.12.015

    authors: Guo X,Li J,Wang J,Fan X,Hu M,Shen Y,Chen H,Zhao J

    更新日期:2014-02-01 00:00:00

  • Sex versus gender differences in schizophrenia: The case for normal personality differences.

    abstract::Schizophrenia has generally been viewed as having a unique preschizophrenia personality or destructive to the personality post-onset. This view is reflected in the scarcity of studies of personality in schizophrenia with the exception of schizotypal personality considered by many as an endophenotype of schizophrenia. ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2017.02.015

    authors: Lewine R,Martin M,Hart M

    更新日期:2017-11-01 00:00:00

  • Weight gain with clozapine: 8-year cohort naturalistic study among hospitalized Chinese schizophrenia patients.

    abstract:OBJECTIVE:Clozapine is associated with significant weight gain. However, it is still debatable whether the majority of weight gain occurs in the early phase of treatment or if weight gain is a persistent side effect. The inconsistent results in previous outpatient studies may be due to many confounding factors, such as...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.schres.2008.10.023

    authors: Bai YM,Chen JY,Chen TT,Lin CY,Chou P,Su TP,Lin CC

    更新日期:2009-03-01 00:00:00

  • High functioning individuals with schizophrenia have preserved social perception but not mentalizing abilities.

    abstract::Social perception and mentalizing are fundamental social cognitive abilities that are related to functioning and are impaired in schizophrenia. A novel approach to examine the relationship between social cognition and community functioning is to first functionally categorize individuals with schizophrenia and then eva...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.01.029

    authors: Karpouzian TM,Alden EC,Reilly JL,Smith MJ

    更新日期:2016-03-01 00:00:00

  • Reduced intra-amygdala activity to positively valenced faces in adolescent schizophrenia offspring.

    abstract::Studies suggest that the affective response is impaired in both schizophrenia and adolescent offspring of schizophrenia patients. Adolescent offspring of patients are developmentally vulnerable to impairments in several domains, including affective responding, yet the bases of these impairments and their relation to n...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.07.023

    authors: Barbour T,Murphy E,Pruitt P,Eickhoff SB,Keshavan MS,Rajan U,Zajac-Benitez C,Diwadkar VA

    更新日期:2010-11-01 00:00:00

  • An evaluation of a stress management program for individuals with schizophrenia.

    abstract::Vulnerability-stress models suggest that training in specific stress management techniques should yield benefits to those suffering from schizophrenia and related disorders. In this paper, we describe an evaluation of the impact of adding a stress management program to other medical and psychosocial interventions for ...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0920-9964(01)00371-1

    authors: Norman RM,Malla AK,McLean TS,McIntosh EM,Neufeld RW,Voruganti LP,Cortese L

    更新日期:2002-12-01 00:00:00

  • Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia.

    abstract:BACKGROUND:Tumor necrosis factor alpha (TNFalpha), a cytokine involved in inflammatory processes, has been implicated in the pathophysiology of schizophrenia. The chromosomal location in the major histocompatibility complex (MHC) region on 6p21.1-21.3, a region with evidence for linkage, suggests a role in susceptibili...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(02)00534-0

    authors: Schwab SG,Mondabon S,Knapp M,Albus M,Hallmayer J,Borrmann-Hassenbach M,Trixler M,Gross M,Schulze TG,Rietschel M,Lerer B,Maier W,Wildenauer DB

    更新日期:2003-12-01 00:00:00

  • Impaired emotional learning and reduced amygdala size in schizophrenia: a 3-month follow-up.

    abstract::Individuals with schizophrenia have difficulties in emotional information processing. A relationship between behavioral variables of emotional processing and structural amygdala alterations in schizophrenia has been proposed but not shown, yet. Morphological studies of amygdala size in schizophrenia have yielded incon...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2004.02.023

    authors: Exner C,Boucsein K,Degner D,Irle E,Weniger G

    更新日期:2004-12-01 00:00:00

  • Cognitive predictors of symptom change for participants in vocational rehabilitation.

    abstract:BACKGROUND:This study explored the relationship between cognitive impairments and their impact on rate of symptom improvement in a 26 week work therapy program. METHOD:Data were abstracted from the archives of 157 outpatients with SCID confirmed DSM-IV diagnoses of schizophrenia or schizoaffective disorder who partici...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.08.010

    authors: Bell MD,Tsang HW,Greig T,Bryson G

    更新日期:2007-11-01 00:00:00

  • Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing physical activity among individuals with schizophrenia.

    abstract:BACKGROUND:Individuals with schizophrenia tend to have low levels of physical activity (PA) which contributes to high rates of physical comorbidities. Valid and reliable methods of assessing PA are essential for advancing health research. Ten years after initial validation of the Short-Form International Physical Activ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.09.010

    authors: Duncan MJ,Arbour-Nicitopoulos K,Subramanieapillai M,Remington G,Faulkner G

    更新日期:2017-01-01 00:00:00

  • The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.

    abstract:BACKGROUND:Clozapine is the drug of choice for patients with unsatisfactory response to routine antipsychotic treatment. Polypharmacy is widely used among patients having clozapine-resistant schizophrenia, although no solid evidence exists for any effective augmentation therapy for this patient population. We aimed to ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.schres.2009.01.002

    authors: Tiihonen J,Wahlbeck K,Kiviniemi V

    更新日期:2009-04-01 00:00:00